![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2023/03/07/2622423/0/en/SEngine-Precision-Medicine-Receives-New-York-State-CLEP-Approval-for-PARIS-Test.html
https://www.globenewswire.com/news-release/2022/09/27/2523759/0/en/SEngine-Precision-Medicine-Announces-New-Non-Small-Cell-Lung-Cancer-Study-at-Johns-Hopkins-University.html
https://www.globenewswire.com/news-release/2022/09/07/2511949/0/en/SEngine-Precision-Medicine-Partners-with-Vincere-Cancer-Center-to-Increase-Access-for-First-Responders-to-Get-Personalized-Cancer-Treatments-via-the-PARIS-Test.html
https://www.globenewswire.com/news-release/2022/07/28/2487662/0/en/SEngine-Precision-Medicine-closes-Series-A-bringing-total-financing-to-19M-enabling-continued-advancement-of-personalized-cancer-treatments.html